Skip to main content
Charles Sawyers, MD, Oncology, New York, NY

CharlesLSawyersMD

Oncology • New York, NY

Professor, Medicine, Weill Cornell Medical College

Request Appointment

Overview of Dr. Sawyers

Dr. Charles Sawyers is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 32 years. Dr. Sawyers accepts several types of health insurance, listed below. He is one of 494 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1985 - 1988
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - Present
  • NY State Medical License
    NY State Medical License 2006 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2008
  • Elected Member The American Society for Clinical Investigation, 1999
  • Investigator Howard Hughes Medical Institute

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Strategies to Identify and Target Cells of Origin in Prostate Cancer  
    Charles Sawyers, MD, Journal of the National Cancer Institute

Lectures

  • GENIE: Lessons Learned and Challenges With Data Curation 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Authored Content

  • Tumor Copy Number Alteration Burden Is a Pan-Cancer Prognostic Factor Associated with Recurrence and DeathSeptember 2018

Press Mentions

  • New Insights Show ASCL1's Role in Neuroendocrine Prostate Cancer, an Aggressive and Treatment-Resistant Type
    New Insights Show ASCL1's Role in Neuroendocrine Prostate Cancer, an Aggressive and Treatment-Resistant TypeOctober 28th, 2024
  • Annual Meeting 2022: Opening Plenary Showcases Cutting-Edge Scientific Program
    Annual Meeting 2022: Opening Plenary Showcases Cutting-Edge Scientific ProgramMay 3rd, 2022
  • With CryoEM, MSK Researchers Obtain Exquisite View of the Androgen Receptor — a Key Protein in Prostate Cancer
    With CryoEM, MSK Researchers Obtain Exquisite View of the Androgen Receptor — a Key Protein in Prostate CancerApril 20th, 2022
  • Join now to see all

Grant Support

  • Understanding Resistance To Next Generation AntiandrogensNational Cancer Institute2012
  • Translational Research In Oncology Training ProgramNational Cancer Institute2011
  • Akt-Independent Pathways Of Phosphoinositide 3-Kinase Dependent TransformationNational Cancer Institute2007–2011
  • Mouse Models For Human Prostate CancerNational Cancer Institute2007–2008
  • Molecular Biology In Clinical Oncology WorkshopNational Cancer Institute2005–2007
  • Mouse Models For Human Prostate CancerNational Cancer Institute2000–2006
  • Phase I Trial Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-Aag, NSC #330National Center For Research Resources2005
  • Phase I Trial Of 17-N-Allylamino-17-Demethoxy Geldanamycin (17-Aag, NSC #330...National Center For Research Resources2004
  • Targeted Therapy Of PTEN NULL Prostate CancerNational Cancer Institute2002
  • Regulation Of The PTEN Tumor Suppressor Gene In Prostate CancerNational Cancer Institute2002
  • Imaging Prostate Cancer Bone MetastasisNational Cancer Institute2000–2002
  • Regulation Of The PTEN Gene In Prostate CancerNational Cancer Institute2000–2001
  • Stem Cell Genes In Prostate Growth And DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2001
  • Role Of C-Able Nuclear Tyrosine Kinase In Normal And Malignant Cell GrowthNational Cancer Institute1995–2000
  • Mouse Models For Prostate CancerNational Cancer Institute1999
  • P53 In Chronic Myelogenous LeukemiaNational Cancer Institute1990–1994

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    GHI PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Charles Sawyers, Dr. Charles Sawyers, MD, Dr. C Sawyers, Dr. Charles L Sawyers